FIGURE

Figure 1

ID

ZDB-FIG-221214-128

Publication

Poudel et al., 2022 - Resveratrol-Mediated Reversal of Doxorubicin-Induced Osteoclast Differentiation

Other Figures

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10

All Figure Page

Back to All Figure Page

Figure 1

Cytotoxicity of doxorubicin and antioxidants on RAW 264.7 cells. RAW 264.7 cells were exposed to different concentrations of Doxorubicin (DOX) (A), Resveratrol (RES) (B) and MitoTEMPO (MT) (C) and an XTT assay was performed. Cells were treated for 3 days with RES and MT, and for 3 h with DOX. One-way ANOVA, Tukey’s multiple comparisons test, *—p ≤ 0.05.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Int. J. Mol. Sci.